News
SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- Investors in Replimune Group, a biotechnology company focused on cancer treatments, witnessed a dramatic collapse in their holdings on July 22. Shares ...
The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.
6hOpinion
The Well News on MSNReleased FDA Files Show Flawed Drug Approval ProcessFor decades, the Food and Drug Administration has been notoriously tight-lipped about why it rejects drugs. It has remained ...
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...
Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...
The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services ...
The Trump administration is inching closer to banning fluoride tablets and drops often prescribed to kids who don’t have ...
11h
Health and Me on MSNFDA Panel Questions Antidepressant Safety For Pregnant Women; Can SSRIs Harm Unborn Babies?When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results